Monday, April 15, 2013
Ambit Biosciences Names Venture Partner To Board
San Diego-based biopharmaceuticals firm Ambit Biosciences announced this morning that it has tapped a venture partner from New Enterprise Associates for a new board member. Ambit said it has named David R. Parkinson, M.D. to its board of directors; Parkinson also serves on the board of Threshold Pharmaceuticals and Zyngenia, in addition to previously sitting on the boards of Facet Biotech. He was previously CEO and President of Nodality become joining NEA.